转运蛋白
非酒精性脂肪肝
法尼甾体X受体
脂肪变性
化学
内质网
下调和上调
内分泌学
未折叠蛋白反应
生物
内科学
生物化学
脂肪肝
医学
核受体
转录因子
炎症
基因
神经炎症
疾病
作者
Yuchang Li,Liting Chen,Lu Li,Chantal M. Sottas,Stephanie K. Petrillo,Anthoula Lazaris,Peter P. Metrakos,Hangyu Wu,Yuji Ishida,Takeshi Saito,Lucy Golden‐Mason,Hugo R. Rosen,Jeremy J. Wolff,Cristina I. Silvescu,Samuel Garza,Garett Cheung,Tiffany Huang,Jinjiang Fan,Martine Culty,Bangyan L. Stiles
出处
期刊:iScience
[Cell Press]
日期:2021-05-01
卷期号:24 (5): 102457-102457
被引量:40
标识
DOI:10.1016/j.isci.2021.102457
摘要
Translocator protein (TSPO, 18 kDa) levels increase in parallel with the evolution of simple steatosis (SS) to nonalcoholic steatohepatitis (NASH) in nonalcoholic fatty liver disease (NAFLD). However, TSPO function in SS and NASH is unknown. Loss of TSPO in hepatocytes in vitro downregulated acetyl-CoA acetyltransferase 2 and increased free cholesterol (FC). FC accumulation induced endoplasmic reticulum stress via IRE1A and protein kinase RNA-like ER kinase/ATF4/CCAAT-enhancer-binding protein homologous protein pathways and autophagy. TSPO deficiency activated cellular adaptive antioxidant protection; this adaptation was lost upon excessive FC accumulation. A TSPO ligand 19-Atriol blocked cholesterol binding and recapitulated many of the alterations seen in TSPO-deficient cells. These data suggest that TSPO deficiency accelerated the progression of SS. In NASH, however, loss of TSPO ameliorated liver fibrosis through downregulation of bile acid synthesis by reducing CYP7A1 and CYP27A1 levels and increasing farnesoid X receptor expression. These studies indicate a dynamic and complex role for TSPO in the evolution of NAFLD.
科研通智能强力驱动
Strongly Powered by AbleSci AI